Ontogeny of central CO2 chemoreception: chemosensitivity in the ventral medulla of developing bullfrogs.
Sites of central CO2 chemosensitivity were investigated in isolated brain stems from Rana catesbeiana tadpoles and frogs. Respiratory neurograms were made from cranial nerve (CN) 7 and spinal nerve 2. Superfusion of the brain stem with hypercapnic artificial cerebrospinal fluid elicited increased fictive lung ventilation. The effect of focal perfusion of hypercapnic artificial cerebrospinal fluid on discrete areas of the ventral medulla was assessed. Sites of chemosensitivity, which are active continuously throughout development, were identified adjacent to CN 5 and CN 10 on the ventral surface of the medulla. In early- and middle-stage tadpoles and frogs, unilateral stimulation within either site was sufficient to elicit the hypercapnic response, but simultaneous stimulation within both sites was required in late-stage tadpoles. The chemosensitive sites were individually disrupted by unilateral application of 1 mg/ml protease, and the sensitivity to bath application or focal perfusion of hypercapnia was reassessed. Protease lesions at CN 10 abolished the entire hypercapnic response, but lesions at CN 5 affected only the hypercapnic response originating from the CN 5 site. Neurons within the chemosensitive sites were also destroyed by unilateral application of 1 mM kainic acid, and the sensitivity to bath or focal application of hypercapnia was reassessed. Kainic acid lesions within either site abolished the hypercapnic response. Using a vital dye, we determined that kainic acid destroyed neurons by only within 100 microm of the ventral medullary surface. Thus, regardless of developmental stage, neurons necessary for CO2 sensitivity are located in the ventral medulla adjacent to CN 5 and 10.
Taylor
Barbara E
BE
Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756-0001, USA.
Harris
Michael B
MB
Leiter
J C
JC
Gdovin
Matthew J
MJ
D000818:Animals; D002245:Carbon Dioxide / Q000494:pharmacology*; D002628:Chemoreceptor Cells / Q000187:drug effects / Q000502:physiology*; D003714:Denervation; D010450:Endopeptidases; D018690:Excitatory Amino Acid Agonists; D005154:Facial Nerve / Q000254:growth & development / Q000502:physiology; D005260:Female; D006935:Hypercapnia / Q000378:metabolism / Q000503:physiopathology; D007608:Kainic Acid; D008297:Male; D008526:Medulla Oblongata / Q000254:growth & development* / Q000502:physiology*; D011892:Rana catesbeiana; D012125:Respiratory Center / Q000254:growth & development / Q000502:physiology; D015656:Respiratory Mechanics / Q000502:physiology; D013127:Spinal Nerves / Q000254:growth & development / Q000502:physiology; D014276:Trigeminal Nerve / Q000254:growth & development / Q000502:physiology; D014630:Vagus Nerve / Q000254:growth & development / Q000502:physiology
D018690:Excitatory Amino Acid Agonists; D002245:Carbon Dioxide; D010450:Endopeptidases; D007608:Kainic Acid